GUIDO, MAURIZIO
 Distribuzione geografica
Continente #
AS - Asia 3.291
SA - Sud America 1.150
NA - Nord America 618
EU - Europa 307
AF - Africa 105
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.474
Nazione #
SG - Singapore 1.641
BR - Brasile 882
US - Stati Uniti d'America 525
CN - Cina 523
VN - Vietnam 427
HK - Hong Kong 256
KR - Corea 162
AR - Argentina 117
BD - Bangladesh 58
DE - Germania 52
IT - Italia 49
RU - Federazione Russa 48
EC - Ecuador 44
IQ - Iraq 42
MX - Messico 39
NL - Olanda 35
ZA - Sudafrica 34
GB - Regno Unito 33
CO - Colombia 29
ID - Indonesia 25
IN - India 25
FI - Finlandia 22
CL - Cile 19
CA - Canada 17
MA - Marocco 16
PK - Pakistan 16
PY - Paraguay 16
UA - Ucraina 15
UY - Uruguay 14
UZ - Uzbekistan 13
VE - Venezuela 13
EG - Egitto 12
TN - Tunisia 12
AG - Antigua e Barbuda 11
KZ - Kazakistan 10
PE - Perù 10
AZ - Azerbaigian 9
KE - Kenya 9
NP - Nepal 9
TR - Turchia 9
JP - Giappone 8
PL - Polonia 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
AT - Austria 5
BH - Bahrain 5
IR - Iran 5
SA - Arabia Saudita 5
SE - Svezia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BG - Bulgaria 4
CY - Cipro 4
FR - Francia 4
IL - Israele 4
JM - Giamaica 4
KG - Kirghizistan 4
LB - Libano 4
CR - Costa Rica 3
ES - Italia 3
GT - Guatemala 3
HN - Honduras 3
JO - Giordania 3
KW - Kuwait 3
LT - Lituania 3
OM - Oman 3
PA - Panama 3
PH - Filippine 3
PS - Palestinian Territory 3
RS - Serbia 3
AU - Australia 2
BW - Botswana 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
GA - Gabon 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
CV - Capo Verde 1
EE - Estonia 1
GE - Georgia 1
IE - Irlanda 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
ML - Mali 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
PR - Porto Rico 1
PT - Portogallo 1
Totale 5.466
Città #
Singapore 560
Hefei 272
Hong Kong 255
Ho Chi Minh City 171
Seoul 159
Beijing 141
Dallas 117
Ashburn 114
Hanoi 77
São Paulo 75
Amsterdam 33
Rio de Janeiro 31
Munich 28
Los Angeles 27
Biên Hòa 20
Brasília 19
Rende 19
Haiphong 18
Dhaka 16
Helsinki 16
New York 16
Brooklyn 15
Fortaleza 15
Mexico City 15
Tianjin 15
Curitiba 14
Johannesburg 14
Belo Horizonte 13
Phoenix 13
Porto Alegre 13
Guayaquil 12
Baghdad 11
Campinas 11
Hải Dương 11
St John's 11
Montevideo 10
Tashkent 10
Cape Town 9
Da Nang 9
Quito 9
Santa Clara 9
Seattle 9
Baku 8
Joinville 8
Lấp Vò 8
Nairobi 8
Salvador 8
Tokyo 8
Bogotá 7
Boston 7
Franca 7
Guarulhos 7
London 7
Moscow 7
Nova Iguaçu 7
Osasco 7
Quảng Ngãi 7
Viamão 7
Warsaw 7
Buenos Aires 6
Can Tho 6
Carapicuíba 6
Frankfurt am Main 6
Karachi 6
Natal 6
Phủ Lý 6
Rome 6
San Francisco 6
Santiago 6
Santo André 6
The Dalles 6
Thái Nguyên 6
Turku 6
Uberlândia 6
Asunción 5
Atlanta 5
Casablanca 5
Chennai 5
Erbil 5
Jakarta 5
Lima 5
Marrakesh 5
Ninh Bình 5
Quilmes 5
Recife 5
San Antonio 5
Sorocaba 5
Stockholm 5
São Gonçalo 5
Ubá 5
Volta Redonda 5
Almaty 4
Bauru 4
Betim 4
Cairo 4
Chicago 4
Goiânia 4
Hortolândia 4
Lahore 4
Londrina 4
Totale 2.768
Nome #
A State-of-the-Art Review of Ophthalmological Indications for a Cesarean Section: Is There a Patient for Whom a Cesarean Section Is Really Indicated? 71
A NEW ULTRASOUND CRITERIUM FOR THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME: PREDICTIVITY OF THE STROMA/AREA RATIO 69
A WHO 2021-based comprehensive scheme outlining sperm parameters’ associations with IVF outcomes in PGT-A cycles 65
Position paper on prevention of surgical site infections in obstetric and gynecological surgery 62
COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine 59
A pilot study of the long-term effects of acipimox in polycystic ovarian syndrome 52
AGEs-related dysfunctions in PCOS: evidence from animal and clinical research 51
A first stage placental site trophoblastic tumor: a case report and review of literature 51
Value of PGT-A when only one or two blastocysts are obtained: propensity-score matching and cost-effectiveness study 50
Alterazioni della secrezione di GH nella sindrome dell'ovaio policistico: un nuovo fattore fisiopatologico 49
EFFECT OF THE INSULIN-SENSITIZING DRUG METFORMIN ON THE GROWTH HORMONE RESPONSE TP GROWTH HORMONE RELEASING HORMONE IN OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: RELATIONSHIP WITH FOOD INGESTION 47
Factors associated with chronic pelvic pain in women with endometriosis: A national study on clinical and sociodemographic characteristics, lifestyles, quality of life, and perceptions of quality of care, during the COVID-19 pandemic 46
Synchronous ovarian and uterine tumours: a case report of an unusual association 45
Alterazioni funzionali: patogenesi, diagnosi e terapia delle cause ovariche 45
Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin 44
VAGINAL MESH REPAIR SYSTEMS FOR PELVIC ORGAN PROLAPSE: ANATOMICAL STUDY COMPARING OUTSIDE-IN VS INSIDE-OUT-TECHNIQUES 43
Differences in AMH levels in the four polycystic ovary syndrome phenotypes based on Rotterdam criteria 43
INSULIN SECRETION IN POLYCYSTIC OVARY DISEASE (PCOD): A MULTIFACTORIAL PROBLEM 43
Vaginal mesh exposure after laparoscopic sacrocervicopexy performed with permanent or absorbable sutures 42
Hypothalamic-pituitary-adrenal axis sensitivity to opioids in women with polycystic ovary syndrome 42
Conservative management of preterm premature rupture of membranes < 30 weeks of gestational age: Effectiveness of clinical guidelines implementation strategies 42
ADOLESCENTE CON ENDOMETRIOSI E PROSPETTIVE RIPRODUTTIVE 41
ALTERATION OF GHRELIN-NEUROPEPTIDE Y NETWORK IN OBESE PATIENTS WITH POLYCYSTIC OVARY SYNDROME: ROLE OF HYPERINSULINISM 41
ADOLESCENTE CON ENDOMETRIOSI E PROSPETTIVE RIPRODUTTIVE. 41
Alterazioni funzionali: patogenesi, diagnosi e terapia delle cause ovariche 41
The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome 40
INFLUENCE OF BODY MASS ON THE HYPOTHALAMIC-PITUITARY-ADRENAL-AXIS RESPONSE TO NALOXONE IN PATIENTS WITH POLYCYSTIC SYNDROME 40
The Italian guidelines on non-invasive and invasive prenatal diagnosis: Executive summary of recommendations for practice the Italian Society for Obstetrics and Gynecology (SIGO) 40
Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome 40
Posterior mesh fixation versus non-fixation in sacrocolpopexy: A randomized clinical trial 40
INSULIN RESISTANCE AND WOMEN'S HEALTH 39
DETRIMENTAL EFFECT OF AGE ON THE OVARIAN RESPONSE TO GONADOTROPIN AND ON PREGNANCY RATE IN POLYCYSTIC OVARIAN SYNDROME WOMEN 39
IS THERE A ROLE FOR ISOLAVONES IN THE THERAPEUTIC APPROCH TO POLYCYSTIC OVARY SYNDROME? RESULTS FROM A PILOT STUDY 39
How should the best human embryo in vitro be? Current and future challenges for embryo selection 39
Alterazioni della secrezione di GH nella sindrome dell'ovaio policistico: un nuovo fattore fisiopatologico 39
INFLUENCE OF BODY MASS ON THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS RESPONSE TO NALAXONE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME 39
PIOGLITAZONE ADMINISTRATION IN HYPERINSULINEMIC WOMEN WITH PCOS DECREASES THE ADRENAL ANDROGEN RESPONSE TO CORTICOTROPHIN-RELEASING FACTOR 38
Role of opioid antagonists in the treatment of women with glucoregulation abnormalities 38
Endocrinology: Differential androgen response to adrenocorticotrophin hormone stimulation and effect of opioid antagonist on insulin secretion in polycystic ovarian syndrome 38
ENDOSCOPIC SURGERY IN OVARIAN ENDOMETRIOSIS: HISTOPATOLOGIC OBSERVATIONS ON THE LOSS OF FOLLICULAR TISSUE DURING TREATMENT 38
Metformin Effects tin Ovarian Ultrasound Appearance and Steroidogenic Function in Normal Weight, Normoinsulinemic Women with Polycystic Ovary Syndrome: A Randomized, Double Blind, Placebo-Controlled Clinical Trial 38
Laparoscopic sacrocolpopexy versus pelvic organ prolapse suspension for surgical management of pelvic organ prolapse: a retrospective study 38
Sex ratio at birth: causes of variation and narrative review of literature 37
Acute insulin response to intravenous glucagon in polycystic ovary syndrome 37
Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol with drospirenone in normal weight women with polycystic ovary syndrome 37
Using a 16-French Resectoscope as an Alternative Device in the Treatment of Uterine Lesions: A Randomized Controlled Trial 36
GLI IPERANDROGENISMI E LA SINDROME DELL'OVAIO POLICISTICO 36
Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome 36
L'INDUZIONE DELL'OVULAZIONE CON FSH PURIFICATO IN PAZIENTI AFFETTE DA SINDROME DELL'OVAIO POLICISTICO: POSSIBILI VANTAGGI DELLA TERAPIA A BASSE DOSI 36
EFFECT OF PIOGLITAZONE TREATMENT ON THE ADRENAL ANDROGEN REPONSE TO CORTICOTROPHIN IN OBESE PATIENTS WITH POLYCYSTIC OVARY SYNDROME 36
Perinatal mental illness and autoimmune diseases: a qualitative sistematic review 36
Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles 36
RECOMBINANT versus URINARY FOLLICLE STIMULATING HORMONE (FSH) IN THE LOW-DOSE REGIMEN IN ANOVULATORY PATIENTS WITH POLICYSTYC OVARY SYNDROME (PCOS): A SAFER AND MORE EFFECTIVE TREATMENT 36
GH RESPONSE TO FOOD INTAKE IN OBESE pcos WOMEN: EFFECT OF METFORMIN 36
Favorable conception and pregnancy involving a male patient affected by chronic myeloid leukemia while taking dasatinib 36
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? 36
Progesterone: The Key Factor of the Beginning of Life 35
The Accuracy of Third-Trimester Ultrasound in Predicting Large for Gestational Age or Macrosomic Fetuses in Diabetic and Non-Diabetic Pregnant Women: A Systematic Review and Meta-Analysis 35
Low AMH levels as a marker of reduced ovarian reserve in young women affected by Down syndrome 35
Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: A clinical, endocrinological, metabolic pilot study 35
TOPICAL HAEMOSTATICS AND SEALANTS IN GYNAECOLOGICAL AND OBSTETRIC 3 SURGERY: STATE OF THE ART 35
Case report: incomplete Cauda Equina Syndrome following a caesarean section with spinal anaesthesia 35
Investigating Unhealthy Behaviors Associated with SF-36 Domains in Women with Endometriosis—Findings from a Web-Based Survey Data Set 35
Ethinylestradiol-Chlormadinone Acetate Combination for the Treatment of Hirsutism and Hormonal Alterations of Normal-Weight Women with Polycystic Ovary Syndrome: Evalutation of Metabolic Impact 35
The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes 34
METFORMIN TREATMENT DOSE NOT AFFECT TOTAL LEPTIN LEVELS AND FREE LEPTIN INDEX IN OBESE PATIENTS WITH POLYCYSTIC OVARY SYNDROME 34
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology 34
Letter to the Editor - DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer 34
The Impact of Metal Nanoparticles on Female Reproductive System: Risks and Opportunities 34
Maternal and fetal outcomes of intraplacental choriocarcinoma complicated by fetomaternal hemorrhage: a systematic review 34
Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study 34
Opioid blockade effect on insulin beta-cells secretory patterns in polycystic ovary syndrome. Oral glucose load versus intravenous glucagon bolus 34
IPERANDROGENISMO E SINDROME DELL'OVAIO POLICISTICO 34
Metaphase‑II oocyte competence is unlinked to the gonadotrophins used for ovarian stimulation: a matched case–control study in women of advanced maternal age 33
OPIOIDS AND GROWTH HORMONE IN POLYCYSTIC OVARY SYNDROME. EFFECT OF FEEDING. 33
Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: Effect of naloxone 33
Sonographic characteristics of ovarian Leydig cell tumor 33
CONTRACCEZIONE ORMONALE E SINDROME DELL'OVAIO POLICISTICO 33
Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: A pilot prospective study 33
Longitudinal metabolic observation of metformin effects during pregnancy in hyperinsulinemic women with polycystic ovary syndrome: A case report 33
Assessment of insulin resistance in lean women with polycystic ovary syndrome 33
Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. 33
Nerve-Sparing Laparoscopic Colposacropexy Using a Percutaneous Surgical System: A Case Report 33
Ultrasound Features and Clinical Outcome of Patients with Ovarian Masses Diagnosed during Pregnancy: Experience of Single Gynecological Ultrasound Center 33
How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation 32
Perimesencephalic Subarachnoid Hemorrhage in Pregnancy 32
Influence of body mass on the hypothalamic-pituitary-adrenal-axis response to naloxone in patients with polycystic ovary syndrome 31
Recurrent Metastatic Pulmonary Synovial Sarcoma during Pregnancy: A Case Report and Literature Review 31
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 31
Endocrinology: Effect of opioid blockade on insulin metabolism in polycystic ovarian disease 31
DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer 31
Postmenarchal Down's syndrome: A theoretical model of growth hormone action on ovarian function 31
EFFETTI SULL'ORMONE DELLA CRESCITA E SUI LIVELLI PLASMATICI DI GLUCOSIO E DI INSULINA DELLA SOMMINISTRAZIONE DI Ghrelin IN DONNE OBESE CON SINDROME DELL'OVAIO POLICISTICO 30
The accuracy of prenatal cell-free DNA screening for sex chromosome abnormalities: a systematic review and meta-analysis 30
The Impact of Thyroid Function on Human Reproduction: A Comprehensive Mini-Review 30
Asymptomatic postmenopausal endometrial thickening: a comparison between transvaginal ultrasound and hysteroscopy in the diagnosis of intracavitary uterine pathologies 30
Botulinum toxin in incontinent women with neurogenic bladder after failure with anticholinergic therapy, long-term results: a pilot study 30
Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome: Dexamethasone and GnRH-agonist administration 30
Tertiary Cytoreduction for Isolated Lymphnode Recurrence (ILNR) Ovarian Cancer in a BRCA2 Mutated Patient: Our Experience and Prevalence of BRCA 1 or 2 Genes Mutational Status in ILNR 30
Haemorrhoidal disease in pregnancy: results from a self-assessment questionnaire administered by means of a social network 30
Totale 3.833
Categoria #
all - tutte 30.447
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.447


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231 0 0 0 0 0 0 1 0 0 0 0 0
2023/20243 0 0 0 0 0 1 0 0 1 0 0 1
2024/20251.724 0 2 1 0 215 197 103 73 302 113 140 578
2025/20263.922 1.034 379 303 770 1.347 89 0 0 0 0 0 0
Totale 5.650